Dudediligence.

Jazz Pharmaceuticals plc

JAZZNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.05BSep ’24$1.09BDec ’24$897.8MMar ’25$1.05BJun ’25$1.13BSep ’25$1.20BDec ’25$1.07BMar ’26$1.21BJun ’26
Net income, by quarter
$215.1MSep ’24$191.1MDec ’24−$92.5MMar ’25−$718.5MJun ’25$251.4MSep ’25$203.5MDec ’25$293.1MMar ’26$192.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$3.09B$3.66B$3.83B$4.07B$4.27B
Operating income$170.3M−$65.5M$578.6M$716.6M−$430.2M
Net income−$329.7M−$224.1M$414.8M$560.1M−$356.1M
Operating cash flow$778.5M$1.27B$1.09B$1.40B$1.36B
Free cash flow$750.9M$1.24B$1.07B$1.36B$1.30B
Cash$591.4M$881.5M$1.51B$2.41B$1.39B
Debt$6.05B$5.72B$5.71B$6.11B$5.36B
Shares outstanding61.6M63.2M62.3M60.6M61.4M